GEHealthcare to nurture 6 Indian startups

18th December 2020
GEHealthcare to nurture 6 Indian startups

Bangalore, December 18  2020:  ‘India EdisonT Accelerator – Startups powered by GE Healthcare’  has announcesdthe launch of its second Cohort, with the enrollment of six remarkable health-tech startups - AarogyaAI, BrainSightAI, Fluid AI, InMed Prognostics, Wellthy Therapeutics and Onward Assist. 
In its second year now, India Edison  Accelerator, the company’s first startup collaboration programm based out of India is helping to mentor and create strategic partners to co-develop healthcare solutions alongside GE’s engineers and scientists. This time the focus is on technology solutions aimed at streamlining healthcare delivery across verticals- Advanced Imaging and Visualization, Precision Diagnosis and Treatment, Computer-aided Detection and Diagnosis, Point-of-Care Diagnostics, Remote Patient Monitoring,  Virtual Hospitals, Data Management and Insights, and Asset Health Monitoring.
The applications received were screened through a three-stage process and the shortlisted entries were evaluated based on the strength of the business idea/plan, maturity and the closeness to productize their solution, team capabilities and relevance to defined focus areas among others. ‘India Edison Accelerator – Startups’ is providing a zero-equity cash-in-grant of $ 10000 to each of the selected startups. In addition, they will have access to mentorship, skill development programs, commercial and regulatory guidance, and data provision as additional benefits.
Says Girish Raghavan, VP, Software Engineering, GE Healthcare South Asia: “The aim of this programme is to harness the brainpower of the start-up ecosystem for developing solutions on the Edison platform for some of the toughest healthcare challenges existing today. We are excited about the collaboration that we are already seeing between the startup community, our colleagues and the Edison platform itself.”
 About the five startups:

  1. AarogyaAI: enables quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment, instantly.
  2. BrainSightAI: is building an MRI-bases SAAS platform, which can transform how neuro-psychiatric disorders are addressed.
  3. Fluid AI: offers data driven solutions backed with AI analytics and insights that can help businesses take smarter decisions with respect to operations, sales, credit etc.
  4. InMed Prognostics: is an artificial intelligence and machine learning based MRI tool, helping neuro-radiologists, neuro physicians and psychiatrists understand the brain better and effects of different conditions.